The European Technology Platform for Nanomedicine and the ENATRANS project launch the first Nanomedicine Translation Advisory Board (TAB), a new instrument to provide free of charge advice and support to ambitious European nanomedicine projects.

The call is open to companies, academics and private researchers in Europe promoting nanomedicine projects. First-in-class recognised experts from industry will deliver concrete and invaluable advice to drive selected nanomedicine projects into innovative products for healthcare.

Apply at: